Overview
Axle Informatics provides specialized informatics solutions for translational research, health informatics, and data science to biomedical research centers and healthcare organizations. It offers customized software and data management platforms that help researchers collect, integrate, analyze, and visualize large research datasets. The company combines biomedical science, software engineering, and program management to automate data aggregation and deliver analytics, dashboards, and decision-support tools that bridge lab findings to clinical applications. Its goal is to advance public health by accelerating the translation of biomedical discoveries into real-world treatments and diagnostics, improving healthcare outcomes.
Work here?Claim your company
Simplify's take
What believers are saying
- August 2026 SOAR awards across NIAID and NCI added multiple funded delivery orders.
- September 2026 SOM bioinformatics BPA reached $11.5M, signaling deeper NIH integration.
- May 2026 SK pharmteco partnership broadens Axle into high-value rare-disease gene therapy programs.
What critics are saying
- Revenue depends on NIH budgets; a 2027 continuing resolution or shutdown freezes task orders.
- The company faces brutal recompete risk after October 2026 if incumbents undercut pricing.
- Axle remains federal-client concentrated; one NIH sourcing shift could cripple cash flow.
What makes Axle unique
- Axle Informatics sits inside NIH workflows, including $11.5M SOM bioinformatics support in September 2026.
- Its 2026 SK pharmteco-NIH partnership extends into rare-disease gene therapy translation.
- GSA Schedule GS-35F-023GA and NIH SOAR wins show repeated federal procurement access.
Help us improve and share your feedback! Did you find this helpful?